title: New drug combination for the treatment of relapsed brain tumors in children.
authors.forename: D
authors.initials: D
authors.lastname: Schuler
authors.forename: P
authors.initials: P
authors.lastname: Somló
authors.forename: J
authors.initials: J
authors.lastname: Borsi
authors.forename: E
authors.initials: E
authors.lastname: Paraicz
authors.forename: T
authors.initials: T
authors.lastname: Révész
authors.forename: G
authors.initials: G
authors.lastname: Kardos
authors.forename: R
authors.initials: R
authors.lastname: Koós
mesh_terms: D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000628:therapy*; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D008936:Mitolactol / Q000008:administration & dosage; D009364:Neoplasm Recurrence, Local / Q000628:therapy*; D010865:Pilot Projects; D011344:Procarbazine / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D011344:Procarbazine; D014750:Vincristine; D008936:Mitolactol